MTATP8P1

Across TCGA pan-cancer cohorts, MTATP8P1 RNA differs between tumor and matched normal tissue in 7 of 18 cancer types tested, making tumor–normal expression one of MTATP8P1’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where MTATP8P1 RNA is repressed in tumor relative to normal tissue. In most cancer types MTATP8P1 is over-expressed in tumor, although a few such as KIRC and LIHC show the opposite, repressed pattern.

KIRC, KICH, and LIHC are the cancer types where MTATP8P1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MTATP8P1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	IV	−0.895	<.001	11	view →
KICH	Female	II,III,IV	+2.130	<.001	8	view →
LIHC	All	All	−0.527	<.001	7	view →
CHOL	All	II,III,IV	−0.944	.017	4	view →
BRCA	All	All	−0.409	<.001	4	view →
PAAD	Female	All	−2.030	<.001	2	view →
COAD	All	All	−0.561	.024	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 7 strongest of 7 lineages.

MTATP8P1–KIRC

Open the KIRC breakdown →